Filter News
Area of Research
- (-) Neutron Science (12)
- Advanced Manufacturing (1)
- Biology and Environment (14)
- Clean Energy (40)
- Computational Biology (1)
- Electricity and Smart Grid (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (28)
- Fusion Energy (5)
- Isotope Development and Production (1)
- Isotopes (5)
- Materials (20)
- Materials for Computing (2)
- National Security (9)
- Nuclear Science and Technology (25)
- Supercomputing (21)
News Topics
- (-) Coronavirus (8)
- (-) Nuclear Energy (2)
- (-) Space Exploration (2)
- 3-D Printing/Advanced Manufacturing (6)
- Artificial Intelligence (5)
- Big Data (2)
- Bioenergy (5)
- Biology (5)
- Biomedical (9)
- Biotechnology (1)
- Chemical Sciences (1)
- Clean Water (2)
- Climate Change (1)
- Composites (1)
- Computer Science (13)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (4)
- Environment (6)
- Fossil Energy (1)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (2)
- Machine Learning (3)
- Materials (11)
- Materials Science (20)
- Mathematics (1)
- Microscopy (2)
- Nanotechnology (8)
- National Security (2)
- Neutron Science (75)
- Physics (8)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (5)
- Security (2)
- Summit (6)
- Sustainable Energy (2)
- Transportation (4)
Media Contacts
Like most scientists, Chengping Chai is not content with the surface of things: He wants to probe beyond to learn what’s really going on. But in his case, he is literally building a map of the world beneath, using seismic and acoustic data that reveal when and where the earth moves.
How did we get from stardust to where we are today? That’s the question NASA scientist Andrew Needham has pondered his entire career.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.